
Abstract Introduction: The US population aged 90+ is rapidly growing and over 50% will develop dementia. Emerging evidence suggests interpersonal relationships may be protective against cognitive decline, but this has not been well studied in the oldest old. We examined associations between marital status and cognitive decline in the LifeAfter90 (LA90) Study testing for gender differences. Methods: LA90 enrolled adults aged 90+ living in Northern California. At baseline, participants self-reported marital status: married, separated, or widowed. Executive function (EF) and verbal episodic memory (VEM) were assessed using the Spanish and English Neuropsychological Assessment Scales every 6 months up to 8 visits. Linear mixed models with random intercepts and slopes tested associations between marital status with EF and VEM. We examined gender-by-marital status interaction terms and gender-stratified models. Results: Participants (n=934) had a mean age of 92.4 ± 2.3 at baseline; 61% widowed, 29% married, and 10% separated. Compared to widowed participants, we found no significant differences in baseline cognition among separated (EF β (95% CI): 0.09 (-0.13, 0.31) and VEM β: -0.01 (-0.24, 0.22)) or married participants (EF β: -0.05 (-0.23, 0.12) and VEM β: -0.01 (-0.24, 0.22)). Decline in EF and VEM did not differ by marital status, and there was no evidence of gender differences. Conclusion: In the oldest old, marital status was not associated with cognitive function or decline, differing from research findings in younger cohorts. Further research should explore how timing and changes in marital status might influence cognition in this understudied population.
Abstract Introduction: Enhanced Recovery After Surgery (ERAS) pathway for Colorectal Surgery (CRS) emphasizes opioid-sparing analgesia to reduce ileus and length of stay (LOS). Our hospital adopted gabapentin as part of postoperative analgesia for CRS. We evaluated the association between perioperative gabapentin use and postoperative delirium (POD). Methods: We retrospectively analyzed 1,165 encounters of patients ≥65 years undergoing elective CRS between 04/2015-06/2023. Encounters requiring critical care, LOS>3 months, or readmissions were excluded. Delirium was identified using chart review, ICD codes and/or new antipsychotic use. Multivariate logistic regression compared delirium rates among three groups: No Gabapentin (NG), low dose (LG) and high dose (HG). Models adjusted for age, race, ethnicity, gender, Charlson Comorbidity Index (CCI), etc. Subgroup analyses investigated delirium by age, gender, CCI. Results: 1,027 individuals were studied: 20.5% NG, 70.8% LG, and 8.7% HG. NG Individuals were older (75.5±7.2) than LG (74.2±6.7) or HG (72.7±6.6), while CCI (6.6±3.8) was similar across groups. The NG group had more patients with dementia (NG 14.2% vs LG 9.5%, p=0.05 vs HG 11.2%). A higher incidence of POD was noted in NG (34.6%) when compared with LG (25.3%, 1.74(1.22-2.47), adj. p=0.002) as well as HG (23.6%, p=0.06). Prior gabapentin exposure did not significantly impact the incidence of postoperative delirium (OR 1.33 (0.86-2.05)) when the cohort was compared based on prior gabapentin exposure. Conclusion: The use of low dose gabapentin postoperatively is associated with lower incidence of delirium compared to absence of gabapentin. However, the absence of gabapentin in our study is a reflection of baseline vulnerability for delirium. Prior exposure to gabapentin had no influence on incident POD. Future prospective trials are required to address the factors to be considered when determining the optimal dosing of gabapentin in older surgical adults.
Abstract Introduction: Ageism refers to prejudice, stereotypes or discrimination based on an individual’s age, and has been consistently linked to important health outcomes. The aim of this study was to test whether exposure to different types of healthcare materials influence older adults’ emotional wellbeing, and whether any observed effects are moderated by internalized (i.e., self-directed) ageism. Methods: Using an experimental manipulation, older adults (N = 176) were randomly assigned to view genuine healthcare materials that were either positively or negatively framed with respect to how they represented older adults. They then completed measures of mood and wellbeing. Results: Older adults exposed to negatively age-framed materials reported poorer mood relative to those exposed to positively age-framed materials. Self-directed ageism emerged as a robust correlate of older adults’ emotional wellbeing (greater demoralization, depression and negative affect) but did not moderate the effect of healthcare materials on mood. Conclusion. Even brief exposure to negatively age-framed healthcare materials is associated with a more negative mood, and this effect is not contingent on the presence of self-directed ageism. However, older adults who reported more negative beliefs about age and aging also reported feeling more depressed and demoralized in general. The findings have broad implications for the framing of healthcare communications targeting older adults.
Abstract Introduction Social robots (SRs) show promise in supporting persons living with dementia (PLWD). However, tools that measure their impact from the perspectives of the dementia community are lacking. This study describes the initial phase of a research program to co-create a Patient-Reported Outcome Measure (PROM) for the use of SRs in dementia care. Methods We conducted 10 co-creation workshops, five online and five in-person, with members of the dementia community (N=51; PLWD, care partners and healthcare providers), informed by a research advisory group (N=8). Results Participants identified 47 candidate PROM items across eight domains: interactions, mental and emotional wellness, activities, caregiver experiences, health, safety and security, quality of life, and independence. Preferences for PROM administration include brief completion time, use of plain language and being available on paper and in digital format. Conclusion This study provides a conceptual foundation for the development of a PROM for use of SRs in dementia care. Findings highlight a broad range of potential outcomes and underscore the value of capturing user-centered perspectives in a systematic way. In the next phases of PROM development, we will develop a draft PROM before evaluating its measurement properties and testing it in real-world settings. This program of research aims to strengthen the evaluation of SRs by facilitating meaningful assessment of user experiences to generate insights that inform healthcare policy, technology development, and empower end-users to make informed decisions about using SRs in dementia care.
Introduction: Sarcopenia, an age-related syndrome characterized by progressive loss of muscle mass, decreased muscle strength, and/or reduced physical performance, is associated with disruptions in amino acid and lipid metabolism. This study aimed to investigate serum metabolic alterations associated with sarcopenia in older adults. Methods: In this cross-sectional study, 50 patients with sarcopenia (diagnosed per 2014 AWGS criteria) were matched 1:1 by age and sex with non-sarcopenic controls from a pool of 2,965 individuals. Assessments included skeletal muscle mass, grip strength, and gait speed. Serum metabolomic profiling was conducted using liquid chromatography-mass spectrometry (LC-MS). The screening of differential metabolites: variable importance in the projection (VIP) > 1 derived from the OPLS-DA model, and adjusted p-value based on false discovery rate (FDR) < 0.05 calculated by two-sample t-test. Results: Among 100 participants aged 60–87 years, individuals with sarcopenia showed significantly lower BMI, grip strength, albumin, and ASMI than controls (all p < 0.05), whereas lipid levels were comparable. PCA suggested weak group separation, whereas PLS-DA achieved clearer discrimination by sex and sarcopenia status. Differential metabolites identified in the sarcopenia group included arginine, leucine and histidinyl-histidine, the latter of which exhibited decreased abundance. Concomitant alterations in the levels of lipid metabolites collectively suggest disrupted amino acid and lipid metabolism. Conclusion: Patterns of dysregulated amino acid and fatty acid metabolism were observed in older adults with sarcopenia. Such metabolic disturbances might serve as candidate biomarkers to inform early detection and nutritional intervention strategies.